Correlation Between Amylyx Pharmaceuticals and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and BridgeBio Pharma, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and BridgeBio Pharma.
Diversification Opportunities for Amylyx Pharmaceuticals and BridgeBio Pharma
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Amylyx and BridgeBio is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and BridgeBio Pharma
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the BridgeBio Pharma. But the etf apears to be less risky and, when comparing its historical volatility, Amylyx Pharmaceuticals is 1.01 times less risky than BridgeBio Pharma. The etf trades about -0.02 of its potential returns per unit of risk. The BridgeBio Pharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 889.00 in BridgeBio Pharma on August 30, 2024 and sell it today you would earn a total of 1,860 from holding BridgeBio Pharma or generate 209.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amylyx Pharmaceuticals vs. BridgeBio Pharma
Performance |
| Timeline |
| Amylyx Pharmaceuticals |
| BridgeBio Pharma |
Amylyx Pharmaceuticals and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amylyx Pharmaceuticals and BridgeBio Pharma
The main advantage of trading using opposite Amylyx Pharmaceuticals and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
| BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |